Proactive Investors - Run By Investors For Investors

In the news: MYCELX Technologies

In the news: MYCELX Technologies

Imogen Whiteside has just put out her latest piece: MYCELX Technologies*† — 2015 Financial Results & Outlook, 19 May 2016. MYCELX offers a technologically differentiated water purification solution that has been adopted by a range of blue chip clients across the oil and gas industry, in both the upstream and downstream space. It has announced its 2015 financial results and its latest outlook. Revenue was in line with 2014 at US$13.6m, with a robust gross profit margin of 53%. The company achieved a 16% YoY reduction in SG&A, leading to an adjusted negative EBITDA of US$1.7m, with net cash at the year end standing at US$3.7m, with its line of credit balances paid off. Consistent achievement of >50% gross margins has been underpinned by high-margin lease contracts, in addition to repeat media sales.
Lease renewals in the Middle East are key to underpinning baseline revenue in the company’s core market. Revenue for the period was strongly (78%) weighted towards the Middle East, with repeat business from high-profile clients, including SABIC and affiliates, backing revenues. The MYCELX system is installed in four sites in Jubail City, Saudi Arabia, with two operating leases being extended during the year with SABIC, and a two-year extension on a further SABIC lease being signed post-period end at a value of US$5m. A plant turnaround project in Qatar in 1H15 provided a cornerstone for operational progress during the year, with the MYCELX system being particularly suited to treating the potentially high-contaminant washdown water to stringent discharge requirements within a tight timeframe.
We maintained our BUY recommendation, with a target price of 80p. We derive our target price from our base case DCF model, assuming no new contract upside in 2016, and sustained gross margins of 50-60% going forward.

This content has been approved under section 21(1) of the FMSA 2000 by RFC Ambrian Limited ("RFC Ambrian") for communication only to eligible counterparties and professional clients as those terms are defined by the rules of Financial Conduct Authority. The contents are not directed at retail clients as RFC Ambrian does not provide investment advisory services to retail clients.  RFC Ambrian publishes this document as non-independent research which is a marketing communication under the Conduct of Business rules. It has not been prepared in accordance with the regulatory rules relating to independent research, nor is it subject to the prohibition on dealing ahead of the dissemination of investment research. It does not constitute a personal recommendation and does not constitute an offer or a solicitation to buy or sell any security. Neither RFC Ambrian nor any of its directors, officers, employees or agents shall have any liability, howsoever arising, for any error or incompleteness of fact or opinion in it or lack of care in its preparation or publication; provided that this shall not exclude liability to the extent that this is impermissible under the law relating to financial services. All statements and opinions are made as of the date on the face of this document and are not held out as applicable thereafter. This document is intended for distribution only in those jurisdictions where RFC Ambrian is permitted to distribute its research. In particular, it is not intended for distribution in and is not directed as persons in the United States.  On the date of this document, RFC Ambrian, RFC Ambrian's holding company, persons connected with it and their respective directors may have a long or short position in any of the investments mentioned in this document.
RFC Ambrian is a member of the London Stock Exchange and is regulated and authorised by the Financial Conduct Authority. RFC Ambrian is registered in England and Wales no. 4236075. Its registered office is at Level 5, Condor House, 10 St Paul’s Churchyard, London EC4M 8AL.

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use